---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-047425"
form_type: "8-K"
ticker: "HCTI"
cik: "0001839285"
company_name: "Healthcare Triangle, Inc."
filed_at: "2025-05-23T23:59:59+00:00"
generated_at: "2026-05-20T15:23:30.302918+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Nasdaq notifies HCTI of delisting over warrant dilution concerns

## Summary
- Nasdaq notified HCTI on May 20, 2025, of intent to delist under Rule 5101 due to public interest concerns from warrant reset provisions.
- Warrants issued in Feb 27, 2025 private placement (Series A & B) contain reset clauses that can cause substantial shareholder dilution.
- Company must present written views to Nasdaq Hearing Panel by May 30, 2025.
- Company plans to submit a compliance plan and also apply for OTCQB trading as a backup if delisted.

## SEC filing metadata
- accession: 0001213900-25-047425
- form_type: 8-K
- ticker: HCTI
- cik: 0001839285
- company_name: Healthcare Triangle, Inc.
- filed_at: 2025-05-23T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1839285/000121390025047425/0001213900-25-047425-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1839285/000121390025047425/ea0243319-8k_healthcare.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-047425
- JSON: https://secwatch.observer/filing/0001213900-25-047425.json
- Plain text: https://secwatch.observer/filing/0001213900-25-047425.txt

## Key facts
- Listing & Compliance Notices
  Healthcare Triangle, Inc. received a nasdaq delisting notice notice regarding other (rules 5101).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Rules: 5101
  source text: May 20, 2025, Healthcare Triangle, Inc. (the “Company”) received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), stating that based on its review of the Company’s public filings with the Securities and Exchange Commission (the “SEC”), its staff has determined to delist the Company’s securities pursuant to its discretionary authority under Listing Rule 5101. Specifically, as set forth in the letter, Nasdaq’s staff determined that the Company’s issuance of securities pursuant to the Company’s private placement, dated February 27, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/1839285/000121390025047425/0001213900-25-047425-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.